| 摘要 |
The present invention is directed to the treatment of paroxysmal extreme pain disorder (PEPD) comprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)- prolinamide or a pharmaceutically acceptable salt, solvate or prodrug thereof. |
